Phase1 First in Human Ascending Dose Study to Evaluate the Safety and Tolerability of FC-12738 in Health Adults
Clinical trial NCT05978908 · COMPLETED
Trial details
- NCT number
- NCT05978908
- Sponsor
- Neurodegenerative Disease Research Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-20
- Primary completion
- 2024-06-03
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.